BEUDAMED
    FDA Adverse Event Injury Summary report: N

    REPLACEMENT HEART VALVE

    MDR report key: 5125249 · Received October 2, 2015

    Report

    Report Number
    2015691-2015-02611
    Event Type
    Injury
    Date Received
    October 2, 2015
    Date of Event
    October 14, 2014
    Report Date
    September 7, 2015
    Manufacturer
    EDWARDS LIFESCIENCES
    Product Code
    DYE
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    GM
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    ADDITIONAL MANUFACTURER NARRATIVE - THE DEVICE WAS NOT RETURNED TO MANUFACTURER AS IT REMAINS IMPLANTED. ATTEMPTS TO OBTAIN ADDITIONAL INFORMATION WERE UNSUCCESSFUL. WITHOUT RETURN OF THE DEVICE OR ADDITIONAL INFORMATION THE REPORTED CLINICAL OBSERVATION CANNOT BE CONFIRMED. EDWARDS WILL CONTINUE TO REVIEW AND MONITOR ALL EVENTS. TRENDS ARE MONITORED ON A MONTHLY BASIS AND IF ACTION IS REQUIRED, APPROPRIATE INVESTIGATION WILL BE PERFORMED.

    Description of Event or Problem · 1

    AS REPORTED THROUGH EUROPEAN CONGRESS "TRANSCATHETER VALVE-IN-VALVE (VIV) IMPLANTATION EXPERIENCE IN 5 DIFFERENT CATHETER VALVES IN THREE DIFFERENT BIOPROSTHESES."THE AUTHOR PRESENTED A RETROSPECTIVE STUDY FROM 2009 TO SEPTEMBER 2014. SIX HUNDRED FORTY TWO (642) TAVI PROCEDURES WERE PERFORMED DURING THE TIME PERIOD, IN WHICH 31 WERE VIV REPRESENTING 5% OF TOTAL CASES. THE THREE BIOPROSTHESES WERE: MITROFLOW (N=24) , PERIMOUNT MAGNA (N=6) ) AND CRYOLIFE O¿BRIAN (N=1). RELATED THIS CONGRESS´ PRESENTATION THE ARTICLE "SINGLE INSTITUTION EXPERIENCE WITH TRANSCATHETER VALVE-IN-VALVE IMPLANTATION EMPHASIZING STRATEGIES FOR CORONARY PROTECTION" AUTHOR: DANIELE CAMBONI, ET AL. PUBLISHED ON ANN THORAC SURG 2015:99:1532-8. THERE WERE 3 BIOPROSTHETIC VALVE SIZES INVOLVED IN THESE 6 VALVE IN VALVE, 21, 23 AND 25. IN THIS CASE A 23MM PERICARDIAL VALVE IMPLANTED IN THE PATIENT REQUIRED A VALVE IN VALVE WITH A 26MM TRANSCATHETER VALVE. AS CONFIRMED THE VALVES DESCRIBED IN THIS ARTICLE WERE IMPLANTED 8-12 YEARS BEFORE, SOME OF THESE PATIENTS HAD RENAL INSUFFICIENCY. NO ADDITIONAL INFORMATION PROVIDED.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    653024 REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 3000TFX

    Patients

    Seq Age Sex Outcome Treatment
    1